What if you'd held LKFT?
A $1,000 investment in Lakefront Biotherapeutics (LKFT) at the month-end close of 2012-02 would be worth $1,628 at the close of 2026-09 — +62.8% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $7,351.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2012
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2012 | $1,000 | — |
| 2013 | $997 | -0.3% |
| 2014 | $877 | -12.0% |
| 2015 | $2,979 | +239.7% |
| 2016 | $3,041 | +2.1% |
| 2017 | $4,441 | +46.1% |
| 2018 | $4,346 | -2.2% |
| 2019 | $9,798 | +125.5% |
| 2020 | $4,689 | -52.1% |
| 2021 | $2,612 | -44.3% |
| 2022 | $2,102 | -19.5% |
| 2023 | $1,926 | -8.4% |
| 2024 | $1,303 | -32.3% |
| 2025 | $1,549 | +18.9% |
| 2026 | $1,350 | -12.9% |
Best and worst month-end to buy
The best single month-end close to have bought LKFT was 2014-10 ($13.99): $1,000 then is $2,036 today. The worst was 2020-01 ($223): $1,000 then is $128.
FAQ
What would $1,000 in LKFT be worth today?
A $1,000 investment in Lakefront Biotherapeutics (LKFT) at the start of 2012 would be worth about $1,628 today, a total return of +62.8%. Dividends are reinvested in these figures.
What were the best and worst years for LKFT?
Lakefront Biotherapeutics (LKFT)'s strongest calendar year since 2012 was 2015, a +239.7% return — $1,000 held through that year became about $3,397 by year-end. Its weakest year was 2020, at -52.1%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in LKFT have grown?
Investing $100 at the end of every month since 2012-02 would have grown to about $13,210 on $17,600 invested.
Did LKFT beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $7,351. LKFT trailed the S&P 500 by +77.9% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Lakefront Biotherapeutics (LKFT) historical total-return data from 2012-02 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.